Sort
23,748 grants matching “melanoma”
Using genetically engineered mouse models of brain tumors to develop therapeutic nanoparticles & biomaterials
$644,838Eric C Holland · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Structural Biology of GTPase Activating Proteins
$644,685Robert Byrd · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Randomized Trial of a Social Media-Delivered Intervention Targeting Indoor Tanning Users
$644,505Jerod L Stapleton · University Of Kentucky · R01 · FY2019 · CA
Impact of mutation burden on cancer growth and the immune landscape
$644,404Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Impact of mutation burden on cancer growth and the immune landscape
$644,401Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Aim 2: Network-level modeling of single-agent and combination therapy
$644,322Peter Karl Sorger · Harvard Medical School · P50 · FY2014 · GM
Tools to Analyze Morphology and Spatially Mapped Molecular Data
$644,203Joel H Saltz · State University New York Stony Brook · U24 · FY2016 · CA
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS
$644,129Pavithra Viswanath · University Of California, San Francisco · R01 · FY2022 · CA
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$643,856Calvin J Kuo · Stanford University · R01 · FY2023 · CA
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
$643,676Mark A. Lemmon · Yale University · R01 · FY2024 · CA
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$643,620Cheng Zhu · Georgia Institute Of Technology · U01 · FY2021 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
$643,599Ronen Marmorstein · University Of Pennsylvania · R01 · FY2021 · CA
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$643,552Calvin J Kuo · Stanford University · R01 · FY2022 · CA
Reducing Skin Cancer Risk in Childhood Cancer Survivors
$643,350Alan C Geller · Harvard School Of Public Health · R01 · FY2017 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$643,054Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A plasticity and reprogramming paradigm for therapy resistance at the single cell level
$642,885Arjun Raj · University Of Pennsylvania · U01 · FY2019 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model
$642,825Ryan C Fields · Washington University · R01 · FY2017 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
$642,782Ronen Marmorstein · University Of Pennsylvania · R01 · FY2023 · CA
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)
$642,768James R. Heath · California Institute Of Technology · R01 · FY2012 · CA
Developing Imaging and Analysis Tools for Lymphoscintigraphy in Lymphedema
$642,639Jaewon Yang · Ut Southwestern Medical Center · R21 · FY2025 · EB
Background-free molecular imaging using modulated photoacoustics and targeted contrast agent
$642,422Robert M Dickson · Georgia Institute Of Technology · R01 · FY2022 · EB
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
$642,410Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$642,352Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$642,352Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment
$642,347Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2012 · CA